Quest Diagnostics Inc. Stock Rises 4.4%, Outperforms Market

Dow Jones
04/22

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Quest Diagnostics Inc. rose 4.4% to $205.04 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.6% to 7,064.01 and Dow Jones Industrial Average falling 0.6% to 49,149.38.

This was the stock's fourth consecutive day of gains.

Quest Diagnostics Inc. closed 4.0% below its 52-week high of $213.50, which the company achieved on February 27th.

The stock demonstrated a mixed performance when compared to some of its peers, as UnitedHealth Group Inc. rose 7.0% to $346.01, IQVIA Holdings Inc. fell 0.6% to $175.69, and Centene Corp. rose 2.17% to $39.14.

Trading volume totaled 2.4 million, compared to the 50-day average of 955,123.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

April 21, 2026 16:35 ET (20:35 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10